Objective Insulin-like growth factor I (IGF-I) and dioxin-like polychlorobiphenyls (DL-PCBs) have been associated with the pathogenesis of several diseases like cancer, diabetes and growth disorders. Because it has been suggested that organohalogenated contaminants could influence IGF-I levels in adults, the potential relationship between DL-PCBs and IGF-I serum levels was studied in 456 healthy adults from a representative sample of the general population of the Canary Islands (Spain). Design Free circulating serum levels of IGF-I and IGFBP-3 were measured through an ELISA methodology, while the serum levels of the 12 DL-PCBs congeners (IUPAC numbers # 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, and 189) were measured by gas chromatography/mass spectrometry (GC-MS). Results DL-PCBs 156 and 167, Total DL-PCBs body burden (∑PCBs: sum over the 12 measured DL-PCBs), and Total toxic burden (in terms of toxic equivalence to dioxins: ∑TEQs) showed a trend of inverse association with IGF-I serum levels in the whole studied population. After adjusting for potential confounders, including gender, body mass index (BMI), age, and IGF-binding protein-3 (IGFBP-3), younger (18–45 years) women with lower BMI (<27 kg/m2) and detectable levels of DL-PCB-156 showed significantly lower IGF-I levels than those in the same age and BMI subgroup with non-detectable levels of DL-PCB-156 (p<0.001). Similarly, ∑PCBs and ∑TEQs showed a tendency to an inverse association with IGF-I levels in the same group of women (p=0.017 and p=0.019 respectively). Conclusions These findings suggest that DL-PCBs could be involved in the regulation of the IGF-system in a way possibly influenced by gender, age and BMI. Although these results should be interpreted with caution, such circumstances could contribute to explain the development of diseases associated to the IGF system.
References
[1]
Binoux M (1995) The IGF system in metabolism regulation. Diabete Metab 21: 330–337.
[2]
Laviola L, Natalicchio A, Giorgino F (2007) The IGF-I signaling pathway. Curr Pharm Des 13: 663–669.
[3]
Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346–1353.
[4]
Sherlock M, Woods C, Sheppard MC (2011) Medical therapy in acromegaly. Nat Rev Endocrinol 7: 291–300.
[5]
Dunger DB, Ong KK, Sandhu MS (2003) Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm Res 60: Suppl 3131–135.
[6]
Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, et al. (2003) Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 58: 213–219.
[7]
Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, et al. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41: 351–357.
[8]
Brabant G, Wallaschofski H (2007) Normal levels of serum IGF-I: determinants and validity of current reference ranges. Pituitary 10: 129–133.
[9]
Baibas N, Bamia C, Vassilopoulou E, Sdrolias J, Trichopoulou A, et al. (2003) Dietary and lifestyle factors in relation to plasma insulin-like growth factor I in a general population sample. Eur J Cancer Prev 12: 229–234.
[10]
Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11: 862–867.
[11]
Succurro E, Arturi F, Grembiale A, Iorio F, Laino I, et al. (2010) Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol 163: 75–80.
[12]
Crowe FL, Key TJ, Allen NE, Appleby PN, Overvad K, et al. (2011) A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Hum Biol 38: 194–202.
[13]
Hall K, Hilding A, Thoren M (1999) Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest 22: 48–57.
[14]
Boada LD, Lara PC, Alvarez-Leon EE, Losada A, Zumbado ML, et al. (2007) Serum levels of insulin-like growth factor-I in relation to organochlorine pesticides exposure. Growth Horm IGF Res 17: 506–511.
[15]
Croutch CR, Lebofsky M, Schramm KW, Terranova PF, Rozman KK (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin (HxCDD) alter body weight by decreasing insulin-like growth factor I (IGF-I) signaling. Toxicol Sci 85: 560–571.
[16]
Dickerson SM, Cunningham SL, Patisaul HB, Woller MJ, Gore AC (2011) Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology 152: 581–594.
[17]
Safe SH (1994) Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 24: 87–149.
[18]
Kimbrough RD (1995) Polychlorinated biphenyls (PCBs) and human health: an update. Crit Rev Toxicol 25: 133–163.
[19]
Tanabe S (1988) PCB problems in the future: foresight from current knowledge. Environ Pollut 50: 5–28.
[20]
Donato F, Zani C, Magoni M, Gelatti U, Covolo L, et al. (2008) Polychlorinated biphenyls and thyroid hormone serum concentrations among people living in a highly polluted area: a cross-sectional population-based study. Environ Res 108: 380–386.
[21]
Fitzgerald EF, Belanger EE, Gomez MI, Hwang SA, Jansing RL, et al. (2007) Environmental exposures to polychlorinated biphenyls (PCBs) among older residents of upper Hudson River communities. Environ Res 104: 352–360.
[22]
Kang JH, Park H, Chang YS, Choi JW (2008) Distribution of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) in human serum from urban areas in Korea. Chemosphere 73: 1625–1631.
[23]
Henriquez-Hernandez LA, Luzardo OP, Almeida-Gonzalez M, Alvarez-Leon EE, Serra-Majem L, et al. (2011) Background levels of polychlorinated biphenyls in the population of the Canary Islands (Spain). Environ Res 111: 10–16.
[24]
Van den Berg M, De Jongh J, Poiger H, Olson JR (1994) The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit Rev Toxicol 24: 1–74.
[25]
(IARC) IAfRoC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. IARC Monographs 1–42: 367. Available at: http://monographs.iarc.fr/ENG/Monographs？/suppl367/suppl367.pdf.
[26]
Fitzgerald EF, Belanger EE, Gomez MI, Cayo M, McCaffrey RJ, et al. (2008) Polychlorinated biphenyl exposure and neuropsychological status among older residents of upper Hudson River communities. Environ Health Perspect 116: 209–215.
[27]
Longnecker MP, Michalek JE (2000) Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 11: 44–48.
[28]
Philibert A, Schwartz H, Mergler D (2009) An exploratory study of diabetes in a First Nation community with respect to serum concentrations of p,p'-DDE and PCBs and fish consumption. Int J Environ Res Public Health 6: 3179–3189.
[29]
Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, et al. (2011) Serum dioxins and polychlorinated biphenyls are associated with growth among Russian boys. Pediatrics 127: e59–68.
[30]
Cocchi D, Tulipano G, Colciago A, Sibilia V, Pagani F, et al. (2009) Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring. Toxicol Appl Pharmacol 237: 127–136.
[31]
Zumbado M, Goethals M, Alvarez-Leon EE, Luzardo OP, Cabrera F, et al. (2005) Inadvertent exposure to organochlorine pesticides DDT and derivatives in people from the Canary Islands (Spain). Sci Total Environ 339: 49–62.
[32]
Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, et al. (2005) Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 14: 48–52.
[33]
Zumbado M, Luzardo OP, Lara PC, Alvarez-Leon EE, Losada A, et al. (2010) Insulin-like growth factor-I (IGF-I) serum concentrations in healthy children and adolescents: relationship to level of contamination by DDT-derivative pesticides. Growth Horm IGF Res 20: 63–67.
[34]
Koppen G, Covaci A, Van Cleuvenbergen R, Schepens P, Winneke G, et al. (2002) Persistent organochlorine pollutants in human serum of 50–65 years old women in the Flanders Environmental and Health Study (FLEHS). Part 1: Concentrations and regional differences. Chemosphere 48: 811–825.
[35]
Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, et al. (1989) Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18: 495–500.
[36]
Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, et al. (2006) The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93: 223–241.
[37]
Henderson KD, Goran MI, Kolonel LN, Henderson BE, Le Marchand L (2006) Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15: 2298–2302.
[38]
Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C (1999) Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol 17: 813–817.
[39]
Schneider HJ, Saller B, Klotsche J, Marz W, Erwa W, et al. (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 154: 699–706.
[40]
Cerna M, Maly M, Grabic R, Batariova A, Smid J, et al. (2008) Serum concentrations of indicator PCB congeners in the Czech adult population. Chemosphere 72: 1124–1131.
[41]
Zubero MB, Ibarluzea JM, Aurrekoetxea JJ, Rivera J, Parera J, et al. (2009) Serum levels of polychlorinated dibenzodioxins and dibenzofurans and PCBs in the general population living near an urban waste treatment plant in Biscay, Basque Country. Chemosphere 76: 784–791.
[42]
Kanbur-Oksuz N, Derman O, Kinik E (2004) Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages. Turk J Pediatr 46: 315–321.
[43]
Andersson PL, Blom A, Johannisson A, Pesonen M, Tysklind M, et al. (1999) Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: In vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes. Arch Environ Contam Toxicol 37: 145–150.
[44]
DeCastro BR, Korrick SA, Spengler JD, Soto AM (2006) Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol 40: 2819–2825.
[45]
Salehi F, Turner MC, Phillips KP, Wigle DT, Krewski D, et al. (2008) Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev 11: 276–300.
[46]
Pliskova M, Vondracek J, Canton RF, Nera J, Kocan A, et al. (2005) Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum. Environ Health Perspect 113: 1277–1284.
[47]
Leijs MM, van Teunenbroek T, Olie K, Koppe JG, ten Tusscher GW, et al. (2008) Assessment of current serum levels of PCDD/Fs, dl-PCBs and PBDEs in a Dutch cohort with known perinatal PCDD/F exposure. Chemosphere 73: 176–181.
[48]
Serra Majem L, Cabrera Leon A, Sierra Lopez A (2000) [Conclusions of the Canary Islands Nutrition Survey (1997–98). Foundations for a nutrition policy in Canary Islands]. Arch Latinoam Nutr 50: 62–70.
[49]
Lewitt MS (1994) Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 23: 3–15.
[50]
Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, et al. (2007) Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999–2002 National Health and Nutrition Examination Survey. Environ Res 103: 413–418.
[51]
Lee DH, Lee IK, Steffes M, Jacobs DR Jr (2007) Extended analyses of the association between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 30: 1596–1598.
[52]
Uemura H, Arisawa K, Hiyoshi M, Satoh H, Sumiyoshi Y, et al. (2008) Associations of environmental exposure to dioxins with prevalent diabetes among general inhabitants in Japan. Environ Res 108: 63–68.
[53]
Pelletier C, Doucet E, Imbeault P, Tremblay A (2002) Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T(3) concentration, and resting metabolic rate. Toxicol Sci 67: 46–51.
[54]
Scarth JP (2006) Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Xenobiotica 36: 119–218.
[55]
Tekle M, Gromadzinska J, Joksic G, Antic R, Nilsson R, et al. (2010) Plasma levels of insulin-like growth factor-I, insulin-like growth factor binding protein-1, coenzyme Q10 and vitamin E in female populations from Poland, Serbia and Sweden. Environ Int 36: 188–194.
[56]
Brian JV, Harris CA, Scholze M, Backhaus T, Booy P, et al. (2005) Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect 113: 721–728.
[57]
Yang F, Xu Y, Pan H, Wu D (2008) Induction of hepatic cytochrome P4501A1/2B activity and disruption of thyroglobulin synthesis/secretion by mono-ortho polychlorinated biphenyl and its hydroxylated metabolites in rat cell lines. Environ Toxicol Chem 27: 220–225.
[58]
Luzardo OP, Almeida-Gonzalez M, Henriquez-Hernandez LA, Zumbado M, Alvarez-Leon EE, et al. (2012) Polychlorobiphenyls and organochlorine pesticides in conventional and organic brands of milk: Occurrence and dietary intake in the population of the Canary Islands (Spain). Chemosphere [Epub ahead of print].
[59]
Agency EFS (2010) Monitoring dioxins in food and feed. EFSA Journal 8: 1385–1408. Available at: http://www.efsa.europa.eu/en/scdocs/scdo？c/1385.htm.
[60]
Gonzalez CA, Riboli E (2010) Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer 46: 2555–2562.
